SynBio Coalition Urges Passage of the Bipartisan Innovation Act
Washington, DC – Today, the Synthetic Biology (SynBio) Coalition released the following statement urging passage of the Bipartisan Innovation Act:
“We urge Congress to move expeditiously to pass the Bipartisan Innovation Act, which includes multiple provisions, including the Endless Frontiers Act and Supply Chain Resilience Fund, that will advance the synthetic biology industry and provide growth opportunities across the country. Once implemented, this legislation will authorize important new recognitions for synthetic biology across multiple sectors and will promote economic growth opportunities that translate into more jobs and stronger onshore supply chains for the United States, all while reducing our nation’s reliance on foreign countries for products and materials. The members of the SynBio Coalition are poised to invest in research & development and build new manufacturing facilities and plants to support scaling of domestic production of critical supplies, ranging from essential medicines to consumer goods. Now is the time for Congress to act to unlock greater innovation for synthetic biology.”
Founded by three leading synthetic biology companies, the SynBio Coalition is a non-partisan group of business leaders and stakeholders dedicated to advancing synthetic biology as a driver of technological innovation and economic growth. The SynBio Coalition aims to turn the US into the home of the world’s most secure and technologically advanced biomanufacturing industry.
###